Paying users zone. Data is covered by .

  • Get to Bristol-Myers Squibb Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

$15.99

Income Statement Quarterly Data

Difficulty: Beginner

Bristol-Myers Squibb Co., Consolidated Income Statement (quarterly data)

USD $ in millions

 
3 months ended Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Net product sales
Alliance and other revenues
Revenues
Cost of products sold
Gross margin
Marketing, selling and administrative
Research and development
Operating income
Other income (expense), net
Earnings before income taxes
Provision for income taxes
Net earnings (loss)
Noncontrolling interest
Net earnings (loss) attributable to BMS
Source: Bristol-Myers Squibb Co., Quarterly and Annual Reports
Item Description The company
Revenues Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Bristol-Myers Squibb Co.'s revenues increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
Operating income The net result for the period of deducting operating expenses from operating revenues. Bristol-Myers Squibb Co.'s operating income declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level.
Earnings before income taxes Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Bristol-Myers Squibb Co.'s earnings before income taxes declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level.
Net earnings (loss) The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Bristol-Myers Squibb Co.'s net earnings (loss) declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level.
Net earnings (loss) attributable to BMS The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Bristol-Myers Squibb Co.'s net earnings (loss) attributable to BMS declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level.

Top